Vaya Knowledge Hub · India

Prescription weight management in India

Modern obesity care can include nutrition, activity, behavioural support and, for some patients, prescription medication. The right pathway depends on clinical assessment.

The useful question is not “what is the strongest weight-loss drug?” It is “what treatment, if any, is appropriate for my health, risks and goals?” Prescription medicines are one part of a broader medical weight-management pathway.

Why obesity is treated as a health condition

Body weight is influenced by biology, environment, sleep, medicines, health conditions, food access, activity and behaviour. For some people, lifestyle changes alone do not produce or maintain clinically meaningful weight reduction. Medical treatment can therefore include more than advice to eat less and exercise more.

Where GLP-1 medicines fit

GLP-1 receptor agonists are one category used in metabolic medicine. Particular products have indications in diabetes and/or chronic weight management. They affect pathways involved in appetite and satiety, but they also have side effects, contraindications and product-specific dosing requirements.

What a good treatment pathway includes

  • A genuine clinical assessment before prescribing
  • A clear explanation of benefits, limitations and risks
  • Product-specific dosing instructions
  • A way to review side effects and tolerability
  • Nutrition and activity guidance appropriate to the individual
  • Progress review based on health as well as weight
  • A plan for maintenance, interruption or discontinuation

Why follow-up matters

A prescription is the beginning of treatment, not the end. Response can change as dose changes, and side effects or other health issues may require review. Long-term weight management also raises questions about maintaining muscle, nutrition quality, activity and what happens if medication is stopped.

What Vaya provides

Vaya is structured as a doctor-led medical weight-management service rather than a medicine storefront. Eligibility is assessed in a doctor conversation. The base membership starts from ₹699 per month and supports the ongoing care layer. Medication is separate if prescribed.

FAQs

Is prescription treatment suitable for everyone with overweight?

No. Suitability depends on the specific medicine's indication and an individual medical assessment.

Is GLP-1 treatment a replacement for nutrition and activity?

No. Clinical trials and medical programs generally consider medication alongside lifestyle intervention.

Is weight the only outcome that matters?

No. Depending on the patient, clinicians may also consider metabolic health, functional goals, side effects, nutrition and other health measures.

Related guides